Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $228.21 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $102.73 | 1 | $0 (2023) |
| CSL Behring | $46.33 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $33.25 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $20.53 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $13.38 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $11.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.47 | 1 | AstraZeneca Pharmaceuticals LP ($17.47) |
| 2023 | $116.11 | 2 | Janssen Scientific Affairs, LLC ($102.73) |
| 2021 | $63.77 | 3 | CSL Behring ($27.46) |
| 2018 | $11.99 | 1 | E.R. Squibb & Sons, L.L.C. ($11.99) |
| 2017 | $18.87 | 1 | CSL Behring ($18.87) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/27/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Rare Disease | ||||||
| 07/18/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2023 | Janssen Scientific Affairs, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $102.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2021 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Gastroenterology | ||||||
| 07/28/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.99 | General |
| Category: Cardiovascular | ||||||
| 09/28/2017 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Critical Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 574 | 581 | $414,627 | $68,691 |
| 2022 | 6 | 547 | 554 | $404,597 | $68,846 |
| 2021 | 5 | 548 | 561 | $412,258 | $69,775 |
| 2020 | 5 | 693 | 707 | $527,690 | $85,251 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 187 | 189 | $116,991 | $25,096 | 21.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 143 | 145 | $166,750 | $23,583 | 14.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 181 | 183 | $100,650 | $16,106 | 16.0% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 47 | 47 | $19,458 | $2,530 | 13.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 16 | 17 | $10,778 | $1,376 | 12.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 159 | 163 | $187,450 | $28,907 | 15.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 155 | 155 | $95,945 | $21,982 | 22.9% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 147 | 149 | $81,950 | $13,012 | 15.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 54 | 54 | $22,356 | $2,684 | 12.0% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 21 | 22 | $13,948 | $1,941 | 13.9% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 11 | 11 | $2,948 | $319.47 | 10.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 163 | 166 | $190,824 | $28,457 | 14.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 171 | 178 | $100,177 | $24,297 | 24.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 145 | 146 | $87,683 | $12,956 | 14.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 52 | 52 | $21,528 | $2,392 | 11.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 17 | 19 | $12,046 | $1,673 | 13.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 224 | 225 | $258,750 | $37,471 | 14.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 217 | 227 | $124,850 | $28,302 | 22.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 159 | 160 | $99,040 | $13,936 | 14.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 69 | 69 | $28,566 | $3,338 | 11.7% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 24 | 26 | $16,484 | $2,203 | 13.4% |
About Dr. Andrew Nakamoto, M.D
Dr. Andrew Nakamoto, M.D is a Emergency Medicine healthcare provider based in Gulfport, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1417198490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Nakamoto, M.D has received a total of $228.21 in payments from pharmaceutical and medical device companies, with $17.47 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($228.21).
As a Medicare-enrolled provider, Nakamoto has provided services to 2,362 Medicare beneficiaries, totaling 2,403 services with total Medicare billing of $292,564. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine
- Location Gulfport, MS
- Active Since 03/20/2009
- Last Updated 03/19/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1417198490
Products in Payments
- XARELTO (Drug) $116.11
- Kcentra (Biological) $46.33
- XIFAXAN (Drug) $20.53
- ANDEXXA (Biological) $17.47
- BRILINTA (Drug) $15.78
- ELIQUIS (Drug) $11.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Gulfport
Dr. Ronnie Ali, Do, DO
Emergency Medicine — Payments: $3,700
Dr. Mallory Blakeslee, D.o, D.O
Emergency Medicine — Payments: $971.27
Dr. Drew Weber, M.d, M.D
Emergency Medicine — Payments: $745.89
Joshua Thomas, M.d, M.D
Emergency Medicine — Payments: $267.26
Larry Couvillon, M.d, M.D
Emergency Medicine — Payments: $262.96
Carol Smith, M.d, M.D
Emergency Medicine — Payments: $230.74